Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|May 1, 1977
Pharmacokinetics of methsuximide and a major metabolite in dogsM R Dobrinska, P G WellingJournal of Clinical Pharmacology|April 18, 2001
Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databasesA D Rodrigues, G A Winchell, M R DobrinskaJournal of Pharmaceutical and Biomedical Analysis|December 1, 1994
Fully automated methods for the determination of hydrochlorothiazide in human plasma and urineJ Y Hsieh, C Lin, B K Matuszewski, et al.Journal of Pharmaceutical and Biomedical Analysis|August 1, 1996
An automated sample preparation and high performance liquid chromatographic method for the determination of MK-591, a novel leukotriene biosynthesis inhibitor, in human plasmaC Lin, J Y Hsieh, B K Matuszewski, et al.Journal of Clinical Pharmacology|February 1, 1976
Pharmacokinetics of 125I-iothalamate and 131I-o-iodohippurate in manP G Welling, A Mosegaard, M R Dobrinska, et al.Journal of Chromatography. B, Biomedical Applications|April 21, 1995
Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detectionJ D Dru, J Y Hsieh, B K Matuszewski, et al.Clinical Pharmacology and Therapeutics|November 1, 1977
Error dependent on renal function when monoexponential equation assumed. Serum clearances of 125I-iothalamate and 131I-o-iodohippurateJ J MacKichan, M R Dobrinska, P G Welling, et al.Biopharmaceutics & Drug Disposition|November 1, 1991
Bioavailability of fluvoxamine given with and without foodJ Van Harten, P Van Bemmel, M R Dobrinska, et al.Journal of Chromatography|June 8, 1984
Sensitive high-performance liquid chromatographic assay using electrochemical detection for a novel prodrug ester of methyldopa, pivaloyloxyethyl 3-(3,4-dihydroxyphenyl)-2-methylalaninate, in plasma and urineD G Musson, W C Vincek, M R Dobrinska, et al.Clinical Pharmacology and Therapeutics|July 1, 1987
Biotransformation of sulindac in end-stage renal diseaseT P Gibson, M R Dobrinska, J H Lin, et al.Pageof 3